Quick Answer
Bionano Genomics, Inc. reported Long Term Debt of $0.00 for the year ending 2021.
- Bionano Genomics, Inc. showed a decrease of -100.0% in Long Term Debt from 2020 to 2021.
- This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 1, 2022.
- XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $9.01 million | Q1 2019: $18.38 million | Q2 2019: $18.62 million | Q3 2019: $18.78 million | Q2 2020: $1.78 million | Q3 2020: $1.78 million | Q1 2021: $14.87 million | Q2 2021: $0.00 | Q3 2021: $0.00.
- Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $16.33 million | Fiscal year 2019: $0.00 | Fiscal year 2018: $9.03 million | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: